Situación actual del dolor crónico en España: iniciativa" Pain Proposal" A Torralba, A Miquel, J Darba Revista de la Sociedad Española del Dolor 21 (1), 16-22, 2014 | 179 | 2014 |
The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patients J Darbà, G Ramírez, A Sicras, P Francoli, S Torvinen, ... International Journal of Chronic Obstructive Pulmonary Disease, 2335-2345, 2015 | 60 | 2015 |
Relationship between global severity of patients with Alzheimer’s disease and costs of care in Spain; results from the co-dependence study in Spain J Darbà, L Kaskens, L Lacey The European Journal of Health Economics 16, 895-905, 2015 | 46 | 2015 |
Disability-adjusted-life-years losses in postmenopausal women with osteoporosis: a burden of illness study J Darbà, L Kaskens, N Pérez-Álvarez, S Palacios, JL Neyro, J Rejas BMC Public Health 15, 1-10, 2015 | 44 | 2015 |
Exploring the current status of neuroendocrine tumours: a population-based analysis of epidemiology, management and use of resources J Darbà, A Marsà BMC cancer 19, 1-7, 2019 | 41 | 2019 |
Parallel imports of pharmaceuticals in the European Union J Darbà, J Rovira Pharmacoeconomics 14 (Suppl 1), 129-136, 1998 | 40 | 1998 |
Assessment of potential measures in models of progression in Alzheimer disease T McLaughlin, M Buxton, T Mittendorf, W Redekop, L Mucha, J Darba, ... Neurology 75 (14), 1256-1262, 2010 | 34 | 2010 |
A review of the value of innovation in inhalers for COPD and asthma JC Virchow, CA Akdis, J Darba, R Dekhuijzen, S Hartl, G Kobelt, A Roger, ... Journal of market access & health policy 3 (1), 28760, 2015 | 32 | 2015 |
Relationship between patient dependence and direct medical-, social-, indirect-, and informal-care costs in Spain J Darbà, L Kaskens ClinicoEconomics and Outcomes Research, 387-395, 2015 | 29 | 2015 |
A systematic review of cost–effectiveness analyses of pharmacogenetic-guided dosing in treatment with coumarin derivatives TI Verhoef, WK Redekop, J Darba, M Geitona, DA Hughes, U Siebert, ... Pharmacogenomics 11 (7), 989-1002, 2010 | 29 | 2010 |
Identification of factors involved in medication compliance: incorrect inhaler technique of asthma treatment leads to poor compliance J Darbà, G Ramírez, A Sicras, L Garcia-Bujalance, S Torvinen, ... Patient preference and Adherence, 135-145, 2016 | 28 | 2016 |
Pharmaceutical pricing and reimbursement in Spain J Rovira, J Darba The European Journal of Health Economics 2 (1), 39-43, 2001 | 28 | 2001 |
Epidemiology and management of parathyroid gland disorders in Spain over 15 years: a retrospective multicentre analysis J Darbà, A Marsà PLoS One 15 (3), e0230130, 2020 | 27 | 2020 |
Cost-effectiveness analysis of insulin degludec compared with insulin glargine u100 for the management of type 1 and type 2 diabetes mellitus–from the Spanish National Health … P Mezquita-Raya, J Darbà, M Ascanio, A Ramirez de Arellano Expert review of pharmacoeconomics & outcomes research 17 (6), 587-595, 2017 | 27 | 2017 |
Efficacy of second-generation-antipsychotics in the treatment of negative symptoms of schizophrenia: a meta-analysis of randomized clinical trials J Darbà, A Minoves, E Rojo, F Jimenez, J Rejas Revista de Psiquiatría y Salud Mental (English Edition) 4 (3), 126-143, 2011 | 27 | 2011 |
Patient preferences for osteoporosis in Spain: a discrete choice experiment J Darba, G Restovic, L Kaskens, MA Balbona, A Carbonell, P Cavero, ... Osteoporosis international 22, 1947-1954, 2011 | 27 | 2011 |
Pharmaceutical expenditure in Spain: evolution and cost containment measures during 1998–2001 J Darbá The European Journal of Health Economics, formerly: HEPAC 4, 151-157, 2003 | 25 | 2003 |
Cost data assessment in multinational economic evaluations: some theory and review of published studies. RG Halliday, J Darba Applied health economics and health policy 2 (3), 149-155, 2003 | 25 | 2003 |
Costs of surviving meningococcal disease in Spain: evaluation for two cases of severe meningitis and septicaemia J Darbà, L Kaskens, M Hark, C Wright Vaccine 32 (39), 5006-5012, 2014 | 23 | 2014 |
Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: a … A Sicras-Mainar, L Sánchez-Álvarez, R Navarro-Artieda, J Darbà Lipids in health and disease 17, 1-16, 2018 | 22 | 2018 |